India’s pharmaceutical workforce records 16% discrepancy rate: AuthBridge reports 

Natco wins patent battle to launch generic ‘Risdiplam’

DRRA17 minutes ago 0

FDA Approves Libtayo for Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma

DRRA57 minutes ago 0

Novo joins MASH dealmaking surge with $4.7B Akero buyout

DRRA3 hours ago 0

Third Circuit Court Rejects Novo Nordisk Challenge to Inflation Reduction Act

DRRA3 hours ago 0